Business context and reporting period
The supplied filing is IKONICS Corporation’s unaudited Form 10-Q for the quarter ended March 31, 2020; it does not identify TeraWulf Inc. as the registrant. This company-name mismatch should be verified before relying on the summary. IKONICS reports four segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX), and Advanced Material Solutions (AMS).
Key financial results
| Metric | Q1 2020 | Q1 2019 / comparison |
|---|---|---|
| Net sales | $3.497 million | $3.529 million; down 0.9% |
| Gross profit / margin | $1.153 million / 33.0% | $1.009 million / 28.6% |
| Operating loss | $811,000 | $552,000 |
| Net loss | $587,000; $0.30 per share | $455,000; $0.23 per share |
| Operating cash flow | $(427,000) | $(618,000) |
| Cash and cash equivalents | $1.605 million at March 31 | $964,000 at December 31, 2019 |
| Short-term investments | $980,000 at March 31 | $2.205 million at December 31, 2019 |
| Total debt | $2.789 million, including current portion | $2.822 million at December 31, 2019 |
Cash, cash equivalents, and short-term investments totaled approximately $2.6 million at quarter-end. The company had a $2.05 million asset-secured line of credit with no borrowings outstanding. Current assets were $7.508 million versus current liabilities of $1.317 million. No separate overall gross-margin guidance was provided.
Material changes and segment performance
- Sales were nearly flat year over year, but gross profit rose $144,000 and gross margin improved 4.4 percentage points, principally reflecting improved margins at Chromaline, IKONICS Imaging, and AMS.
- SG&A increased to $1.781 million from $1.382 million, mainly due to $365,000 in one-time CEO transition costs. The resulting operating loss widened despite higher gross profit.
- Segment sales: Chromaline $1.964 million, down from $2.029 million; IKONICS Imaging $970,000, down from $1.089 million; DTX $113,000, up from $93,000; AMS $450,000, up from $318,000. AMS reported that its largest customer planned to reduce orders beginning in Q2.
- Cash from investing activities was $1.105 million, largely reflecting $1.225 million in proceeds from maturing short-term investments. Capital expenditures were $135,000. Cash used in financing was $36,000 of debt principal payments.
- The company recorded a $239,000 income tax benefit, including recognition of eligible NOL carryback claims under the CARES Act; it also recorded a $214,000 valuation allowance against deferred tax assets.
Outlook, risks, and unusual items
Management said COVID-19 had already reduced sales activity and expected a significant decline in demand in Q2 2020 and beyond, with likely material adverse effects on sales, margins, operations, and financial condition. The company remained operational as an essential business, with safety measures and remote-work arrangements. Management said the duration and financial impact could not be reasonably estimated.
After quarter-end, the company secured a $1.2 million Small Business Administration Paycheck Protection Program loan. The loan may be forgiven in whole or in part if applicable criteria are met. Management said the loan, liquidity, and available credit could help mitigate pandemic effects. Planned 2020 capital spending was reduced from an earlier estimate of approximately $204,000.
The company had previously failed its debt-service coverage covenant at December 31, 2019, but obtained a waiver and amended the covenant calculation. The filing describes the effective start of the amended annual calculation inconsistently: one passage says March 31, 2020, while another says December 31, 2020. Future violations without waivers could adversely affect liquidity. Substantially all assets collateralize the term loan and credit line.
Other stated risks include customer and supplier slowdowns, supply interruptions, lower product demand, workforce disruption, customer credit concerns, reduced liquidity, and possible asset impairments. The filing reports no legal proceedings, no off-balance-sheet arrangements, and no material changes to disclosure controls.
Important facts for investors to verify
- Confirm that this IKONICS filing is the intended filing, given the request metadata identifies TeraWulf Inc.
- Verify the date and terms of the $1.2 million PPP loan and whether any portion qualified for forgiveness.
- Resolve the filing’s conflicting descriptions of when the amended debt-service covenant calculation began, and confirm covenant compliance and any subsequent waivers.
- Assess subsequent sales, margins, customer order reductions, collections, and inventory levels in light of management’s COVID-19 outlook.
- Review the one-time CEO transition charges, the deferred-tax valuation allowance, and the recoverability of deferred tax assets.